Arrowhead Pharmaceuticals, Inc. (ARWR) Social Stream
ARROWHEAD PHARMACEUTICALS INC (ARWR) Price Targets From Analysts
Use the tables below to see what analysts covering ARROWHEAD PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-15 | 9 | $106 | $44 | $89.7 | $38.07 | 135.62% |
| 2021-11-24 | 8 | $106 | $45 | $89.777 | $38.07 | 135.82% |
| 2021-12-15 | 8 | $106 | $45 | $90.111 | $38.07 | 136.7% |
| 2022-01-12 | 7 | $106 | $45 | $89.5 | $38.07 | 135.09% |
| 2022-01-28 | 7 | $106 | $46 | $89.625 | $38.07 | 135.42% |
| 2022-03-24 | 6 | $106 | $36 | $89.142 | $38.07 | 134.15% |
| 2022-04-26 | 7 | $106 | $36 | $89.142 | $38.07 | 134.15% |
| 2022-05-10 | 8 | $106 | $35 | $87.75 | $38.07 | 130.5% |
| 2022-05-11 | 8 | $106 | $35 | $80.444 | $38.07 | 111.31% |
| 2022-05-16 | 8 | $100 | $35 | $77.777 | $38.07 | 104.3% |
| 2022-05-18 | 9 | $100 | $35 | $78.5 | $38.07 | 106.2% |
| 2022-05-26 | 9 | $100 | $35 | $76.6 | $38.07 | 101.21% |
| 2022-06-03 | 9 | $110 | $35 | $77.6 | $38.07 | 103.84% |
| 2022-06-17 | 9 | $110 | $35 | $75.9 | $38.07 | 99.37% |
| 2022-08-04 | 9 | $110 | $39 | $76.3 | $38.07 | 100.42% |
| 2022-08-08 | 9 | $110 | $39 | $76.4 | $38.07 | 100.68% |
| 2022-08-09 | 9 | $110 | $39 | $75.6 | $38.07 | 98.58% |
| 2022-10-11 | 10 | $110 | $39 | $72.454 | $38.07 | 90.32% |
| 2022-10-24 | 10 | $110 | $32 | $71.818 | $38.07 | 88.65% |
| 2022-11-10 | 10 | $110 | $33 | $71.181 | $38.07 | 86.97% |
| 2022-11-29 | 10 | $110 | $31 | $71 | $38.07 | 86.5% |
| 2022-11-30 | 10 | $110 | $31 | $68.909 | $38.07 | 81.01% |
| 2022-12-08 | 10 | $92 | $31 | $67.09 | $38.07 | 76.23% |
| 2023-01-09 | 10 | $92 | $22 | $65.454 | $38.07 | 71.93% |
| 2023-01-23 | 10 | $90 | $22 | $62.818 | $38.07 | 65.01% |
| 2023-02-06 | 11 | $90 | $22 | $62.181 | $38.07 | 63.33% |
| 2023-02-10 | 11 | $90 | $22 | $62.5 | $38.07 | 64.17% |
| 2023-02-15 | 12 | $90 | $21 | $62.416 | $38.07 | 63.95% |
| 2023-03-21 | 12 | $90 | $21 | $59.692 | $38.07 | 56.8% |
| 2023-04-04 | 11 | $90 | $21 | $58.083 | $38.07 | 52.57% |
| 2023-04-13 | 11 | $90 | $27 | $59.25 | $38.07 | 55.63% |
| 2023-04-25 | 11 | $90 | $27 | $59.666 | $38.07 | 56.73% |
| 2023-04-26 | 12 | $90 | $27 | $61.23 | $38.07 | 60.84% |
| 2023-05-03 | 12 | $90 | $27 | $61.461 | $38.07 | 61.44% |
| 2023-05-05 | 12 | $90 | $27 | $60.153 | $38.07 | 58.01% |
| 2023-05-12 | 11 | $90 | $27 | $60.153 | $38.07 | 58.01% |
| 2023-05-23 | 11 | $90 | $27 | $60.307 | $38.07 | 58.41% |
| 2023-07-17 | 11 | $90 | $27 | $60.846 | $38.07 | 59.83% |
| 2023-07-20 | 12 | $90 | $27 | $61.23 | $38.07 | 60.84% |
| 2023-08-07 | 13 | $90 | $27 | $60.916 | $38.07 | 60.01% |
| 2023-08-09 | 13 | $90 | $27 | $59.846 | $38.07 | 57.2% |
| 2023-08-11 | 12 | $90 | $27 | $59.846 | $38.07 | 57.2% |
| 2023-08-25 | 12 | $90 | $27 | $58.692 | $38.07 | 54.17% |
| 2023-09-19 | 14 | $90 | $27 | $56.857 | $38.07 | 49.35% |
| 2023-10-16 | 14 | $90 | $21 | $56.428 | $38.07 | 48.22% |
| 2023-10-31 | 14 | $90 | $26 | $56.785 | $38.07 | 49.16% |
| 2023-11-16 | 14 | $90 | $26 | $57.538 | $38.07 | 51.14% |
| 2023-11-29 | 14 | $90 | $24 | $57.153 | $38.07 | 50.13% |
| 2023-12-04 | 15 | $90 | $24 | $54.071 | $38.07 | 42.03% |
| 2023-12-05 | 15 | $90 | $24 | $53.357 | $38.07 | 40.15% |
| 2023-12-11 | 15 | $90 | $24 | $53.642 | $38.07 | 40.9% |
| 2023-12-18 | 14 | $90 | $24 | $51.615 | $38.07 | 35.58% |
| 2023-12-19 | 14 | $90 | $24 | $51.384 | $38.07 | 34.97% |
The Trend in the Analyst Price Target
Over the past 30 months, ARWR's average price target has gone down $40.08.
ARWR reports an average of 97.99% for its upside potential over the past 49 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-10 | 10 | 90 | 22 | 62.818 | 33.03 | 90.18% |
| 2023-03-21 | 12 | 90 | 21 | 58.083 | 24.60 | 136.11% |
| 2023-04-13 | 11 | 90 | 27 | 59.250 | 30.50 | 94.26% |
| 2023-08-07 | 13 | 90 | 27 | 60.916 | 30.81 | 97.72% |
| 2023-12-11 | 15 | 90 | 24 | 51.615 | 23.87 | 116.23% |
ARWR Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.64 | 9 | 1 | 4 | 0 | 0 | 14 |
The Trend in the Broker Recommendations
ARWR's average broker recommendation rating worsened by 0.15 over the prior 35 weeks.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how ARROWHEAD PHARMACEUTICALS INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -5131.53% of that group.
- ARWR has a greater upside potential (average analyst target price relative to current price) than 4489.92% of all US stocks.
- In terms of how ARROWHEAD PHARMACEUTICALS INC fares relative to Pharmaceutical Products stocks, note that its average analyst price target is greater than 4665.8% of that group.
- ARROWHEAD PHARMACEUTICALS INC's number of analysts covering the stock is greater than 4347.55% of stocks in the mid market cap category.
Stocks similar to ARROWHEAD PHARMACEUTICALS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are IMGN, HRTX, and ADCT.
View All Top Stocks by Price Target
Make investment decisions regarding ARWR using the data that counts. Try POWR Ratings for free.